Compare Sana Biotechnology Inc (SANA) vs Stitch Fix Inc (SFIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Stitch Fix Inc — how do they compare? Sana Biotechnology Inc trades at $3.75 (market cap $1.13B), while Stitch Fix Inc trades at $3.62 (market cap $497.68M). The key difference: Sana Biotechnology Inc is far larger — about 2.3× Stitch Fix Inc's market cap, and Sana Biotechnology Inc is trading nearer its 52-week high, Stitch Fix Inc nearer its low. Which is the better fit depends on your goals.
| SANA | SFIX | |
|---|---|---|
Market Cap | $1.13B | $497.68M |
Sector | Health | Consumer Cyclical |
52-Week High | $5.92 | $5.83 |
52-Week Low | $2.68 | $3.06 |
Enterprise Value | $1.05B | $385.40M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SANA Biotechnology trades at $3.775, up 4.57% with strong technical momentum as moving averages signal bullish sentiment. The company shows significant financial challenges with negative ROE (-152.87%) and net income (-$244.17M in 2025), though recent analyst upgrades and clinical developments in cell therapy research provide optimism. Cash flow remains negative but improved from -$55M to -$14M year-over-year, while the stock benefits from 82% buy ratings from analysts.
Investment outlook balances high-risk fundamentals against promising biotechnology breakthroughs. The primary opportunity lies in successful clinical trial outcomes and market adoption of engineered cell therapies, while risks include sustained cash burn, execution challenges, and competitive pressures in the genomics space. Wall Street's $9.50 price target suggests substantial upside potential if operational improvements materialize.
Stitch Fix (SFIX) trades at $3.97, down 5.48% today, as the online personal styling service shows mixed signals. While revenue has stabilized around $1.3B annually and losses are narrowing significantly, the company remains unprofitable with a -1.43% net margin. Technical indicators show a bullish trend with strong momentum signals, though oscillators remain neutral. Recent news highlights AI-driven personalization initiatives and active client growth as potential turnaround catalysts.
The stock presents a speculative recovery opportunity with improving fundamentals but carries execution risks. Analyst consensus is cautious with a $4.75 price target (20% upside) but only 27% buy ratings. Key risks include consumer spending pressure and the challenge of achieving sustainable profitability in the competitive retail sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →
